Sequentially combined hormone replacement therapy reduces impedance to flow within the uterine and central retinal arteries in healthy postmenopausal women

American Journal of Obstetrics and Gynecology

Volumn 181, Issue 6, 1999, Pages 1365-1373

  Marchien Van Baal, W ^b   Kenemans, Peter ^a   Stehouwer, Coen D A ^b   Peters Muller, Edith R A ^b   Van Vugt, John M G ^b   Van Der Mooren, Marius J ^b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

Central retinal artery; Hormone replacement therapy; Pulsatility index; Uterine artery

Indexed keywords

DYDROGESTERONE; ESTRADIOL;

ADULT; AMENORRHEA; ARTERY BLOOD FLOW; ARTERY RESISTANCE; ARTICLE; CLINICAL TRIAL; COLOR ULTRASOUND FLOWMETRY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; ESTROGEN THERAPY; FEMALE; FOLLOW UP; HUMAN; LONG TERM CARE; NORMAL HUMAN; OPHTHALMIC ARTERY; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETINA ARTERY; UTERINE ARTERY;

EID: 0033377599     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9378(99)70377-7     Document Type: Article

References (25)

1. 1. Grodstein H, Stampfer MJ, Manson JE, Colditz GA, Willett WC, Rosner B, et al. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease [published erratum appears in N Engl J Med 1996;335:1406]. N Engl J Med 1996;335:453-61.
2. 2. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/Progestin Replacement Study (HERS) Research Group. JAMA 1998;280:605-13.
3. 3. Paganini-Hill A. Estrogen replacement therapy and stroke. Prog Cardiovasc Dis 1995;38:223-42.
4. 4. Brenner DE, Kukull WA, Stergachis A, van Belle G, Bowen JD, McCormick WC, et al. Postmenopausal estrogen replacement therapy and the risk of Alzheimer's disease: a population-based case-control study. Am J Epidemiol 1994;140:262-7.
5. 5. Pines A, Mijatovic V, van der Mooren MJ, Kenemans P. Hormone replacement therapy and cardioprotection: basic concepts and clinical considerations. Eur J Obstet Gynecol Reprod Biol 1997;71:193-7.
6. 6. Vyas S, Gangar K. Postmenopausal oestrogens and arteries. Br J Obstet Gynaecol 1995;102:942-6.
7. 7. Venkov CD, Rankin AB, Vaughan DE. Identification of authentic estrogen receptor in cultured endothelial cells: a potential mechanism for steroid hormone regulation of endothelial function. Circulation 1996;94:727-33.
8. 8. Collins P, Rosano GM, Jiang C, Lindsay D, Sarrel PM, Poole-Wilson PA. Cardiovascular protection by oestrogen: a calcium antagonist effect? Lancet 1993;341:1264-5.
9. 9. Marsh MS, Bourne TH, Whitehead MI, Collins WP, Campbell S. The temporal effect of progestogen on uterine artery pulsatility index in postmenopausal women receiving sequential hormone replacement therapy. Fertil Steril 1994;62:771-4.
10. 10. Hillard TC, Bourne TH, Whitehead MI, Crayford TB, Collins WP, Campbell S. Differential effects of transdermal estradiol and sequential progestogens on impedance to flow within the uterine arteries of postmenopausal women. Fertil Steril 1992;58:959-63.
11. 11. Luckas MJ, Gleeve T, Biljan MM, Buckett WM, Aird IA, Drakeley A, et al. The effect of progestagens on the carotid artery pulsatility index in postmenopausal women on oestrogen replacement therapy. Eur J Obstet Gynecol Reprod Biol 1998;76:221-4.
12. 12. Penotti M, Nencioni T, Gabrielli L, Farina M, Castiglioni E., Polvani F. Blood flow variations in internal carotid and middle cerebral arteries induced by postmenopausal hormone replacement therapy. Am J Obstet Gynecol 1993;169:1226-32.
13. 13. Gangar KF, Vyas S, Whitehead M, Crook D, Meire H, Campbell S. Pulsatility index in internal carotid artery in relation to transdermal oestradiol and time since menopause. Lancet 1991;338:839-42.
14. 14. Belfort MA, Saade GR, Snabes M, Dunn R, Moise KJ Jr, Cruz A, et al. Hormonal status affects the reactivity of the cerebral vasculature. Am J Obstet Gynecol 1995;172:1273-8.
15. 15. Pirhonen JP, Vuento MH, Makinen JI, Salmi TA. Long-term effects of hormone replacement therapy on the uterus and on uterine circulation. Am J Obstet Gynecol 1993;168:620-30.
16. 16. Zalud I, Conway C, Schulman H, Trinca D. Endometrial and myometrial thickness and uterine blood flow in postmenopausal women: the influence of hormonal replacement therapy and age. J Ultrasound Med 1993;12:737-41.
17. 17. Bourne T, Hillard TC, Whitehead MI, Crook D, Campbell S. Oestrogens, arterial status, and postmenopausal women [letter]. Lancet 1990;335:1470-1.
18. 18. Penotti M, Farina M, Sironi L, Barletta L, Gabrielli L, Vignali M. Cerebral artery blood flow in relation to age and menopausal status. Obstet Gynecol 1996;88:106-9.
19. 19. Lantta M, Karkkainen J, Lehtovirta P. Progesterone and estradiol receptors in the cytosol of the human uterine artery. Am J Obstet Gynecol 1983;147:627-33.
20. 20. Bill A. Blood circulation and fluid dynamics in the eye. Physiol Rev 1975;55:383-417.
21. 21. Yudkin PL, Stratum IM. How to deal with regression to the mean in intervention studies. Lancet 1996;347:241-3.
22. 22. Jackson S, Vyas S. A double-blind, placebo controlled study of postmenopausal oestrogen replacement therapy and carotid artery pulsatility index. Br J Obstet Gynaecol 1998;105: 408-12.
23. 23. Hata K, Hata T. Effects of oophorectomy and hormone replacement therapy on ophthalmic artery blood flow velocity waveforms. J Ultrasound Med 1997;16:737-41.
24. 24. Funk JL, Mortel KF, Meyer JS. Effects of estrogen replacement therapy on cerebral perfusion and cognition among postmenopausal women. Dementia 1991;2:268-72.
25. 25. Birge SJ. The role of estrogen in the treatment of Alzheimer's disease. Neurology 1997;48 Suppl 7:S36-41.